Vernon Jon J
Division of Oral Biology, School of Dentistry, University of Leeds, Leeds, UK.
Adv Exp Med Biol. 2025;1472:277-294. doi: 10.1007/978-3-031-79146-8_17.
The balance between health and disease is intrinsically linked to the interactions between microbial communities and the host. This complex environment of antagonism and synergy involves both prokaryotic and eukaryotic cells, whose collaborative metabolic pathways and immunomodulatory elements influence system homeostasis. As with the gut and other niches, the oral microbiome has the capacity to affect distal host sites. The ability to manipulate this environment holds the potential to impact local and systemic disease.With the increasing threat of antimicrobial resistance, novel approaches to reduce the burden of disease are essential. The use of probiotics and prebiotics is one such strategy. Probiotics introduce non-pathogenic bacteria into the environment to compete with pathogens for nutrients and attachment sites, or to produce metabolites that counteract disease aetiologies. Prebiotic compounds enhance the growth of health-associated organisms, offering additional benefits, whilst a conjunctive approach with probiotics potentially holds even greater promise. Though widely studied in the gastrointestinal context, their potential for treating oral diseases, such as dental caries and periodontitis, is less understood. Additionally, the use of microbial transplantations has demonstrated efficacy in other areas, reducing systemic inflammation and recolonising with commensal bacteria. Here we evaluate their use in the oral context and their modulatory impact on overall health.In this chapter, we discuss how pro- and prebiotic strategies seek to modulate both the oral and gut environments to promote oral health and prevent disease. We assess novel approaches for utilising health-associated microorganisms to combat oral disorders, either administered locally in the mouth or imparting influence through immune modulation via the oral-gut axis. By examining available clinical trial data, we aim to further understand the intricacies involved in this discipline. Furthermore, we consider the challenges facing the research community, including optimal candidate organism/compound selection and colonisation retention, as well as considerations for future research.
健康与疾病之间的平衡本质上与微生物群落和宿主之间的相互作用相关联。这种拮抗与协同的复杂环境涉及原核细胞和真核细胞,它们的协作代谢途径和免疫调节元件会影响系统的稳态。与肠道及其他生态位一样,口腔微生物群有能力影响宿主的远端部位。操控这一环境的能力有可能对局部和全身疾病产生影响。随着抗菌药物耐药性威胁的不断增加,减少疾病负担的新方法至关重要。益生菌和益生元的使用就是这样一种策略。益生菌将非致病性细菌引入环境中,与病原体竞争营养物质和附着位点,或者产生对抗疾病病因的代谢产物。益生元化合物可促进与健康相关的生物体生长,带来额外益处,而与益生菌联合使用可能更具前景。尽管在胃肠道方面已得到广泛研究,但它们在治疗口腔疾病(如龋齿和牙周炎)方面的潜力却鲜为人知。此外,微生物移植在其他领域已显示出疗效,可减轻全身炎症并使共生细菌重新定殖。在此,我们评估它们在口腔环境中的应用及其对整体健康的调节作用。在本章中,我们将讨论益生菌和益生元策略如何试图调节口腔和肠道环境以促进口腔健康并预防疾病。我们评估利用与健康相关的微生物对抗口腔疾病的新方法,这些方法既可以在口腔局部施用,也可以通过口腔 - 肠道轴的免疫调节发挥作用。通过研究现有的临床试验数据,我们旨在进一步了解该领域所涉及的复杂性。此外,我们考虑了研究界面临的挑战,包括最佳候选生物体/化合物的选择和定殖保留,以及对未来研究的考量。